Literature DB >> 14334273

NOCICEPTIVE THRESHOLDS AS AFFECTED BY PARENTERAL ADMINISTRATION OF IRRITANTS AND OF VARIOUS ANTINOCICEPTIVE DRUGS.

C A WINTER, L FLATAKER.   

Abstract

Keywords:  AMINOPYRINE; ANALGESICS AND ANTIPYRETICS; ASPIRIN; EXPERIMENTAL LAB STUDY; FLUFENAMIC ACID; INDOLES; INDOMETHACIN; INJECTIONS, INTRAPERITONEAL; IRRITANTS; MEFENAMIC ACID; MORPHINE; PAIN; PHARMACOLOGY; PHENACETIN; QUINONES; RATS; STEARIC ACID

Mesh：

Substances：

Year:  1965        PMID： 14334273

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. 1973.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

2.  The abdominal constriction response and its suppression by analgesic drugs in the mouse.

Authors:  H O Collier; L C Dinneen; C A Johnson; C Schneider
Journal:  Br J Pharmacol Chemother       Date:  1968-02

Review 3.  The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia.

Authors:  B Dubinsky; S Gebre-Mariam; R J Capetola; M E Rosenthale
Journal:  Agents Actions       Date:  1987-02

4.  The analgetic properties of piroxicam in animals and correlation with experimentally determined plasma levels.

Authors:  G M Milne; T M Twomey
Journal:  Agents Actions       Date:  1980-04

5.  An overview of nonsteroidal antiinflammatory agents (NSAIA).

Authors:  W L Norton; M A Meisinger
Journal:  Inflammation       Date:  1977-03       Impact factor: 4.092

6.  Effect of apomorphine on the antinociceptive activity of morphine.

Authors:  Z Dunai-Kovács; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

7.  Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.